Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gsk Plc ADR (NY: GSK )

34.70 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 17, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,555
Open 34.70
Bid (Size) 34.54 (9)
Ask (Size) 34.56 (17)
Prev. Close 34.70
Today's Range 34.70 - 34.70
52wk Range 34.25 - 46.97
Shares Outstanding 5,385,189,617
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sanofi's Run Of Bad Luck Continues As Pharma Giant Tosses Out A Cancer Drug
Shares extended deep losses following a Zantac-inspired downturn last week. 
Via Investor's Business Daily
AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report
 
Via Benzinga

Performance

YTD
-20.54%
-20.54%
1 Month
-14.13%
-14.13%
3 Month
-20.47%
-20.47%
6 Month
-20.03%
-20.03%
1 Year
-18.03%
-18.03%

More News

Read More
GSK's Rare Blood Cancer Candidate Goes Under FDA Review
Via Benzinga
One Suit Down Out Of 3,000 Zantac Related Lawsuits, Says GSK
Via Benzinga
Why IDEAYA Biosciences Shares Plunging Today
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
GSK Confirms Rotavirus Vaccine Shortage, Hits Four African Countries: Report
Via Benzinga
Vir Biotech Shuns FDA Submission Plans For GSK-Partnered COVID-19 Treatment
Via Benzinga
ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Landmark Drug Pricing Reform Bill Passes Congress House
Via Benzinga
Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy
Via Benzinga
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
GSK, PFE, SNY Stocks Fall on Zantac Litigation
Via InvestorPlace
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
Via Investor's Business Daily
Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
Via Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Via Benzinga
Dividend Income Update July 2022
Via Talk Markets
ADDING MULTIMEDIA GSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide
From GSK plc
Via Business Wire
Biotech Investors: August's Key PDUFA Catalysts You Must Know
Via Benzinga
Recap Of Friday's Biotech Catalysts - End of The Day Summary
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.